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The Impact of Hospital Consolidations:
Who is Really Benefitting from M&A’s within Healthcare?
Brent S. Reed
Grand Valley State University
Abstract
The healthcare industry’s position within the American mixed economy has a
complicated history. Healthcare has historically received protections against American
antitrust legislation and the standards used to enforce healthy competition within the
industry. This has led to hundreds of mergers and acquisitions over the last 30 years.
In the last decade, hospital consolidation growth slowed with renewed scrutiny coming
from government bodies like the Federal Trade Commission and Department of Justice.
However, the impact of these mergers and what they mean for the future of healthcare
and the level of government involvement held therein is still widely unknown. As such,
this paper seeks to define, what is the impact on patients and health systems as a result
of these major mergers and acquisitions? Over 30 sources were compiled for this research
that, in aggregate, represented over 150 journal entries, news articles, and long-term
studies. The findings of the research indicate a negative impact of rising costs and poorer
patient outcomes associated with the anticompetitive nature of mergers and acquisitions
within the healthcare industry in the United States. These outcomes are contested by
institutions like the American Hospital Association arguing the importance of cost
distribution to limit organization risk in a volatile environment. More research is needed
to understand how much hospitals and healthcare organizations should consolidate to
ensure financial stability of systems without raising prices or worsening patient outcomes.
Policy makers should take into consideration the need for competition within healthcare to
assure price transparency, control and improved patient outcomes.
Keywords: Hospital Consolidation, Healthcare, Patient Impact,
Antitrust, Competition, Health, Mergers & Acquisitions, Patient, Patient
Care, Herfindahl-Hirschman
Introduction: Mergers and Acquisitions in a “Mixed Economy”
Today, the United States of America (U.S.) operates under the loosely
defined principles of a mixed economy system (Marks, 2012). There are
many definitions of the term “mixed economy” and for the purposes
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of this research paper a simple definition suffices. A mixed economy is,
“an economy in which someeconomy is, “an economy in which some
companies are owned by the government and other companies are not”
(Mixed Economy, n.d.). Now, determining which companies are owned
by the government and which are not is a heated political debate that has
encompassed the country since the 1800’s involving various industries
(Marks, 2012). This longstanding debate has created a foundation of
economic rules and laws that make up the scaffolding of American
economic policy.
The impetus for these debates came when large businesses or “trusts”
were established that took control of large sections of the American
economy during the 1800’s. These sections of the economy were railroads,
oil, steel and sugar. The Federal Trade Commission (FTC) Fact Sheet (n.d.)
regarding antitrust laws offers more information regarding these events.
Two of the most famous trusts were U.S. Steel and Standard
Oil; they were monopolies that controlled the supply of their
product—as well as the price. With one company controlling an
entire industry, there was no competition, and smaller businesses
and people had no choices about from whom to buy. Prices
went through the roof, and quality didn’t have to be a priority…
President Theodore Roosevelt “busted” (or broke up) many trusts
by enforcing what came to be known as “antitrust” laws. The goal
of these laws was to protect consumers by promoting competition
in the marketplace.
There are three core laws that make up the U.S. antitrust legislation signed
into law by President Theodore Roosevelt. They are the Sherman act of
1890, the Clayton Act of 1914, and the Federal Trade Commission Act
of 1914 (The Antitrust Laws, n.d.). The FTC Fact Sheet (n.d.) provides a
good overview of the purpose for each of these acts.
The Sherman Act makes it illegal for competitors to make
agreements with each other that would limit competition. So, for
example, they can’t agree to set a price for a product—that’d be
price fixing. The Act also makes it illegal for a business to be a
monopoly if that company is cheating or not competing fairly…
The Clayton Act helps protect American consumers by stopping
mergers or acquisitions that are likely to stifle competition…
Congress created a new federal agency to watch out for unfair
business practices—and gave the Federal Trade Commission the
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authority to investigate and stop unfair methods of competition
and deceptive practices.
Ever since the implementation of these laws, general American economic
policy has been to foment competition amongst industries (FTC Fact Sheet,
n.d.).
Herfindahl-Hirschman Index (HHI)
Today, the antitrust laws are enforced via the Bureau of Competition
within the FTC and the Antitrust Division in the Department of Justice
(DOJ). Additionally, each state has antitrust laws which are typically
enforced by the Attorney General (FTC Fact Sheet, n.d.). According to the
Department of Justice Antitrust Division, in order to effectively enforce
antitrust laws these agencies typically use a tool, among others, called the
Herfindahl–Hirschman Index (HHI).
The HHI is calculated by squaring the market share of each firm
competing in the market and then summing the resulting numbers.
For example, for a market consisting of four firms with shares of
30, 30, 20, and 20 percent, the HHI is 2,600 (302 + 302 + 202 +
202 = 2,600 (Herfindahl-Hirschman, 2018).
According to the FTC, an HHI in excess of 5,000 is a monopoly. A score
over 2,500 points is considered highly concentrated or non-competitive,
and any time an HHI increases by 200 points within a non-competitive
environment the merger or acquisition responsible for that change would
fall under investigation of the FTC or DOJ (Herfindahl-Hirschman, 2018).
Fulton (2017) illustrates how the healthcare industry has been largely
exempt from this form of antitrust scrutiny. Fulton (2017) uses the HHI to
show how healthcare entities are not only becoming less competitive, but
with regards to competition hospitals have even become monopolistic (see
figures 1 and 2).
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Figure 1.
Mean HHI of MSAs, 2010-16.

Note. Adapted from Fulton, B. D. (2017). Health Care Market Concentration Trends in the United States. Health Affairs, 36(9). From Health Affairs:
https://www.healthaffairs.org/doi/abs/10.1377/hlthaff.2017.0556
Figure 2.
Percentage of MSAs with HHI above 2,500, 2010-16.

Note. Adapted from Fulton, B. D. (2017). Health Care Market Concentration Trends in the United States. Health Affairs, 36(9). From Health Affairs:
https://www.healthaffairs.org/doi/abs/10.1377/hlthaff.2017.0556
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The corresponding decreases in free-market competition shown in Figures
1 and 2 have not gone unnoticed by the FTC or DOJ. During the 80s
and 90s, the FTC was largely unsuccessful in blocking hospital mergers.
However, since 2006, the FTC has successfully sued to stop several hospital
mergers with over 12 investigations ongoing during 2011 (FTC puts
hospital mergers under ‘virtual microscope’, 2011). This year, the FTC
announced new investigations into state sponsored certificates of public
advantage (COPA) and their ability to exempt healthcare organizations
from Antitrust litigation (FTC to Study the Impact of COPAs, 2019).
The FTC’s believes, “COPAs are regulatory regimes, adopted by state
governments that are intended to displace competition among healthcare
providers”(FTC to Study the Impact of COPAs, 2019). The renewed focus
of the FTC and DOJ to litigate against the health industry can be attributed
to the Evanston-Northwestern Case in 2006. The decision in this case is
important because it established that not-for-profit hospitals in urban areas
can increase market power by merging (Gaynor, 2012). The litigation since
2006 has effectively slowed the growth of hospital consolidation, especially
geographically near hospitals, as shown by the lack of curvature on hospital
sections of figure 1 and 2. Nevertheless, slowing hospital consolidation
through litigation has not stopped the increase in prices nor addressed the
already existing monopolies.
HealthCare in a Mixed Economy
Understanding the history of the United States’ economic development
in the context of antitrust legislation provides a critical perspective when
contemplating the trends within a healthcare system because the entire
industry is currently at the top of the debate deciding healthcare’s place
in our mixed economy. Will healthcare maintain some independence from
government ownership? Or, is healthcare destined to become ever more
engrained in government control? Current presidential candidates are
lobbying for greater governmental control over the means of delivering
healthcare in the United States (Warren, 2019). Additionally, new legislation
has been changing the way that systems receive payments with even more
legislative changes projected. Indeed, a major focus of the new legislation
within the United States, specifically the Patient Protection and Affordable
Care Act of 2010 (PPACA, ACA or Obamacare) and the Medicare Access
and CHIP Reauthorization Act of 2015 (MACRA), have been to reduce
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rising healthcare costs. However, the aim to reduce costs as a result of
recent legislation seems to be failing. According to NHE Fact Sheet
(2018) “the U.S. health care spending increased 4.3 percent to reach $3.3
trillion, or $10,348 per person in 2016. The overall share of gross domestic
product (GDP) related to health care spending was 17.9 percent in 2016,
up from 17.7 percent in 2015.” Moreover, Sisko et al. (2019) provides the
cost ex ante from the National Center for Biotechnology Information
stating, “National health expenditures are projected to grow at an average
annual rate of 5.5 percent for 2018-27 and represent 19.4 percent of gross
domestic product in 2027.” Being at the forefront of political discourse
can be problematic for Healthcare industry leaders especially since, “this
debate is unfolding against the backdrop of growing public anger regarding
the unaffordability of health care in the United States—and hospitals and
insurers are two top targets of that backlash” (Kerns, Fontana, Egan, &
Hollander, 2019). It is because of the political discourse that Abelson
(2018) believes current trends within the ever-changing landscape of the
healthcare industry are indicating the need to consolidate health systems
under the belief that consolidations control costs and limit risk. The
attempt to consolidate as a form of protection can be seen through recent
major mergers and acquisitions from actors traditionally within and without
the industry (Abelson, 2018).
Asking the Question – What is the impact of Hospital
consolidations?
What is the impact on patients and health systems as a result of these
major mergers and acquisitions? Finding the answer to this question is the
purpose this research paper. The following literature review provides strong
evidence how hospital consolidations have been permitted to skirt antitrust
laws and have negatively impacted healthcare costs and patient outcomes.
Literature Review
Impact of Mergers and Acquisitions on Prices
Since the 1990’s the United states has seen an increase of mergers
inside of healthcare. Evidence from the initial wave of hospital
consolidation in the 1990s suggested that highly concentrated hospital
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markets correlated with higher hospital prices, despite potential savings
for the merging hospitals, due to consolidated services and operational
efficiencies (Vogt, 2006). Figure 3 summarizes a decade’s worth of
merger studies, most of which indicate that less competition leads to
higher prices (Gaynor, 2012). Abelson (2016) goes on to comment that
price increases from mergers could range from 5% - 60%. There is also
disparity on the impact mergers have on prices dependent on geographic
location. Figure 4 shows Patients in Metropolitan areas are subject to
significantly higher prices due to mergers than their rural counterparts.
The chart identifies 19 of the 25 metropolitan areas with the greatest
hospital consolidation in 2010-2013, and how their prices changed
compared with other areas in the same state.
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Figure 3.
Summary of hospital concentration studies since 2006.

Note. Adapted from Gaynor, M., & Town, R. (2012, June). The Impact of
Hospital Consolidation - update. The Synthesis Project.

94

The Impact of Hospital Consolidations
Figure 4.
Hospital Consolidation and Rising Costs.

Note.
Adapted from Abelson, R. (2018, November 14). When Hospitals Merge
to Save Money, Patients Often Pay More. From The New York Times:
https://www.nytimes.com/2018/11/14/health/hospital-mergers-healthcare-spending.html
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Impact of Mergers and Acquisitions on Patient Outcomes
Not only is there significant evidence that hospital consolidations
increase prices, there is additional evidence that they negatively impact
patient outcomes. According to Haas, Gawande & Reynolds (2018),
“System expansions can have substantial effects on clinical care and patient
safety, particularly when clinicians encounter changes in their practice
setting, patient population, or infrastructure.” This is further evidenced
by the Mulvany (2017) research illustrated in Figure 5. In many areas,
specifically around for-profit mega deals there is a decrease in quality
performance of acquired hospitals initially and over time.
In another study, stemming from the UK where price is controlled
by the government and quality is more easily researched, Gaynor (2012)
showed that forcing health systems to compete reduced patients’ length
of stay and that, for every 10% decrease in market concentration, the
30-day mortality for heart attacks fell by almost 3%. Among groups of
cardiologists, it has been found that patients are more likely to have heart
attacks, visit the ED, be readmitted and die in more highly concentrated
markets (Big hospital mergers lead to better patient care, right? Maybe not,
2019). More research is needed to understand how to address the impact
of hospital consolidations. NCCI Insights (2018) echoes the call for more
information, “hospital consolidation is likely to affect both the quantity and
price of medical services. Forthcoming NCCI research will investigate the
effect of hospital consolidation on prices and utilization of medical services
in workers compensation.”
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Figure 5.
Quality performance of acquired hospitals.

Variable

For-profit
For-profit For- single
acquisition profit acquisition
from
of a non- mega- another for
All
deal
profit
Acquisition acquired profit
(n=137) (n=137)
(n=164)
Impact
hospitals

Nonprofit
merger
of
equals
(n=73)

Non-profit
with single
acquisition
(n-234)

Non-profit
with
system
acquisition
(n=120)

Overall

Year of
Patients
the deal
given beta 1 year after
blockers the deal
2 years
after the
deal

Overall

Year of
30 day
the deal
readmissions 1 year after
the deal
Hip or Knee 2 years
Replacement after the
deal
Patients
who gave
their
hospital a
rating of 9
or 10
ED Median time
from ED
arrival to ED
departure for
admitted ED
patients

Overall
Year of
the deal
1 year after
the deal
2 years
after the
deal

Overall
Year of
the deal
1 year after
the deal
2 years
after the
deal

Note.
Adapted from Mulvany, C. (2017). Hospital M&A Research:. Retrieved 2019
from https://www.hfma.org/content/dam/hfma/document/research_
reports/PDF/56984.pdf: https://www.hfma.org/content/dam/hfma/
document/research_reports/PDF/56984.pdf
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Arguments in favor of Mergers and Acquisitions
With all the above evidence against mergers, why do hospitals and
others within the healthcare industry continue to extol the virtues of
decreasing competition through merging? The first answer comes from a
belief about the American view of healthcare in general, “we often think of
health care as different—that it somehow shouldn’t be ‘market based,’’(Big
hospital mergers lead to better patient care, right? Maybe not, 2019). It is
true that hospitals tend to stem from charitable organizations and operate
on razor thin margins in comparison to other industries because of the
public good they perform. These margins often need to be protected and
risk mitigated. For example, margins are thin enough for hospitals that a
.7% reduction in Medicare reimbursement is worth the risk of paying for
litigation (Hall, Render, Kellen & Lyman, 2019). Moreover, consolidation
lessens risk from litigation and seems to be a major benefit to large health
systems that can support litigation efforts. This power is evidenced by the
outcome of Azar v. Allina Health Services (2019) where the supreme court
overturned the previous ruling in support of the .7% reduction in Medicare
reimbursement mention previously. In addition, in November of 2019
alone, “Capital Health System and dozens of hospitals...filed a separate
lawsuit alleging HHS has maintained billions of dollars in reductions to
Medicare DSH payments, despite a Supreme Court ruling in June that
struck down the payment cuts” (Hundreds of hospitals sue HHS for
cutting Medicare reimbursements, 2019). This type of proactive litigation
cannot be maintained by smaller hospitals.
Claim 1: We will be more cost-effective
Claim 2: Merging will streamline our burdensome supply chain and human
capital operations
Claim 3: Merging will improve care quality
If we accept that the evidence for the claims above is lacking, then what is
the true benefit of M&A? In my experience in one-on-one conversations
with CEOs, they readily acknowledge that many of the common claims
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about M&A don’t hold up to scrutiny. But there is one benefit that almost
everyone acknowledges: Getting bigger provides the system greater leverage
with payers.
Additionally, to combat obstacles around consolidation Willis (2019)
says the three major reasons hospitals seek to consolidate are to be more
cost effective, streamline supply chain and human capital operations and
improve quality. Furthermore, “hospitals have argued that consolidation
benefits consumers with cheaper prices from coordinated services and
other savings” (Abelson, 2018). The American Hospital Association (AHA)
released a report refuting the idea that hospital mergers are anticompetitive.
In the statement below the AHA implies if mergers did not occur in their
research cohort the financial instability of those hospitals would have led to
worse outcomes for communities.
The Center for Healthcare Economics and Policy examined 316
transactions involving 551 hospitals between 2007 and 2012. The
researchers found that the percentage of mergers with an overlap
in at least one metropolitan statistical area (MSA) declined from
60% in 2007 to 32% last year. Moreover, the report found that
90% of transactions involving two parties in the same market
were in MSAs with at least five competing hospitals. In the 20
cases where merger parties overlapped in MSAs with five or fewer
competitors, 16 MSAs had less than 200,000 residents, and 75%
involved a hospital with less than 150 beds. In those transactions,
where hospitals were more likely to be suffering financially there
were clearly tangible benefits that accrued to the community (AHA
makes the case for hospital mergers, 2013).
The AHA’s argument is further strengthened by Craig, Grennan, &
Swanson (2018) who found, “target hospitals save on average $176
thousand (or 1.5 percent) annually”. Furthermore, Schmitt (2017) provides
even larger estimates of the benefits of merging with the 2014 findings
that when considering an aggregate 6.4 percent operating margin of the
hospitals studied, “the observed 4 to 7 percent cost reductions at target
hospitals may be generating substantial economic surplus.”
Even with these claims however, many are countered. Schmitt (2017)
is the same research paper shared skepticism about the reliability of the
research results saying, “precisely identifying the sources of these cost
savings, if and when mergers are necessary to achieve them, and the
circumstances under which cost savings are likely to be passed through
99
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remain important (and largely open) policy questions. The NCCI Insights
(2018) also rebuts the idea asserted by the AHA that cost savings are passed
downstream to patients. Their research found, “Reductions in hospital
operating costs do not translate into price decreases (for patients). Research
to date shows that hospital mergers increase the average price of hospital
services by 6%−18%” (NCCIS, 2018). In defense of the hospitals
In defense of the hospitals that are undertaking consolidation, Willis (2019)
comments, as systems get larger, they should be able to spread their fixed
costs across a larger number of patients, service lines, and sites of care. But
doing that proves to be much more challenging in reality”. When reflecting
on the reality that pro hospital consolidation evidence is lacking Willis
(2019) aptly questions, “If we accept that the evidence for the claims above
is lacking, then what is the true benefit of M&A?”. He continues to answer
his own question which I believe gets to the heart of the matter regarding
hospital consolidations:
In my experience in one-on-one conversations with CEOs, they
readily acknowledge that many of the common claims about M&A
don’t hold up to scrutiny. But there is one benefit that almost
everyone acknowledges: Getting bigger provides the system greater
leverage with payers (Willis, 2019).
Discussion
Most of the current literature referenced earlier utilizes a StructureConduct-Performance (SCP) Study format, which estimates the association
between the price of healthcare services and the structure of the market
that is in question (typically measured by the HHI). Unfortunately, this
methodology requires assessment of difficult-to-measure variables,
including price of services. There are several potential confounding
variables that have challenged researchers seeking to study the impact
of healthcare mergers: heterogeneous prices effects for different
health insurers, hospital products, and hospital locations, the degree of
substitution between hospitals, the relative bargaining ability of hospitals
and insurers, and the premerger price–cost margins of different products
delivered by these hospitals (Croes et al.,2019). Another methodology,
called Event Studies, utilize data from before and after mergers to assess
the impact of the consolidation on price. This methodology requires the
researcher to identify other comparable comparators to hold as controls.
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The price difference from pre vs. post-merger, subtracting the price
difference from the non-merger control group, is the actual effect of the
consolidation. Additionally, Croes et al. (2019) research provides greater
evidence around the difficulty of measurement and the subsequent policy
ramifications around merger scrutiny.
First, it highlights the importance of using a disaggregated
approach rather than the current cluster approach when defining
relevant hospital product markets. Second, it suggests that future
prospective merger analyses should take potential differences
across hospital locations into account. Finally, it asks for a critical
assessment of health insurers’ bargaining ability in merger cases
(Croes, et al., 2019).
Through improved assessment, like that mentioned above, it is believed that
a more accurate understanding when mergers eliminate competition would
inform antitrust litigation and help control the negative impacts around
hospital consolidations. Affirmingly, Landman et al. (2018) argues that the
approach needs to be reframed from a “how much” competition mindset to
a “what type” of competition paradigm as well.
Lower-cost markets appear to benefit from competition among
healthcare systems with well-organized provider networks and
geographic coverage across their market. Health plan competition
also appears to be a significant factor, especially with respect to
encouraging innovation in payment models and plan design within
a market.
In short, more sophisticated models of measurement need to become
more wide spread and accepted to settle the dispute regarding the costs and
benefits of mergers and acquisitions within healthcare. Kerns, Fontana,
Egan, & Hollander (2019) argue that the best method for controlling costs
would be to increase price transparency throughout the entire healthcare
industry in place of allowing mergers and acquisitions. The result of the
Landmen et al. (2018) research also points to the need of transitioning away
from mergers and acquisitions in favor of transparency.
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Lower-cost markets also appear to benefit from organized
mechanisms, including state-sponsored or endorsed reporting
agencies and employer coalitions, for more transparent sharing
of information on provider quality and costs. Interviewees also
believe that greater transparency of quality and cost information
for consumers is necessary, while acknowledging that transparency
tools that have been offered thus far have had limited impact
(Landmen et al., 2018).
By continuing to push transparency, policy makers will be more apt to make
informed decisions that will ensure decreasing the growing healthcare costs
in the United States while ensuring optimum patient outcomes.
Conclusion
What is the impact on patients and health systems as a result of these
major mergers and acquisitions? Patients pay more, receive lower quality
care and participating organizations in the merger may or may not improve
financial stability. In general, mergers and acquisitions have a bleak outlook.
This research provides strong evidence that the FTC and DOJ should
continue investigating mergers and acquisitions within the healthcare
industry to enforce antitrust laws established to promote competition.
Additionally, local, state, and national policy makers should be skeptical of
the purported benefits of large consolidated health systems. This research
implies that patients may be better served if the healthcare industry veers
away from the owned by government portion of the American mixed
economy.
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